51. Physical and biological consequences of incorporation of antiviral agents into virus DNA.
- Author
-
Prusoff WH, Mancini WR, Lin TS, Lee JJ, Siegel SA, and Otto MJ
- Subjects
- Acyclovir pharmacology, Antiviral Agents pharmacology, Bromodeoxyuridine analogs & derivatives, Bromodeoxyuridine pharmacology, Cytarabine analogs & derivatives, Cytarabine pharmacology, DNA, Viral genetics, Idoxuridine analogs & derivatives, Idoxuridine metabolism, Idoxuridine pharmacology, Protein Biosynthesis drug effects, Ribavirin pharmacology, Simplexvirus drug effects, Structure-Activity Relationship, Thymidine analogs & derivatives, Thymidine metabolism, Thymidine pharmacology, Thymine Nucleotides administration & dosage, Thymine Nucleotides metabolism, Transcription, Genetic drug effects, Vidarabine metabolism, Vidarabine pharmacology, Antiviral Agents metabolism, DNA, Viral metabolism, Dideoxynucleosides
- Abstract
The molecular basis for the antiviral activity is discussed for a variety of nucleoside compounds approved for clinical use in the U.S.A. (5-iodo-2'-deoxyuridine, 5-trifluoromethyl-2'-deoxyuridine, 9-beta-D-arabinofuranosyladenine, 9-(2-hydroxyethoxymethyl)guanine), or in clinical trial (E-5-(2-bromovinyl)-2'-deoxyuridine, 1-(2-deoxy-2-fluoro-beta-D-arabinosyl)-5-iodocytosine, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide), or of specific interest to our laboratory (5-iodo-5'-amino-2',5'-dideoxyuridine, 5'-amino-5'-deoxythymidine). The consequence of incorporation of idoxuridine, the 5'-amino analog of thymidine or the 5'-amino analog of idoxuridine into the DNA of herpes simplex virus type 1 on transcription and translation is emphasized.
- Published
- 1984
- Full Text
- View/download PDF